The Beauty Health Company

The Beauty Health Co. engages in manufacturing and selling of serum-based hydradermabrasion systems and aesthetic products. The company was founded in 1997 and is headquartered in Long Beach, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

The Beauty Health Company reports robust Q4 earnings and eyes international expansion opportunities

The Beauty Health Company delivered strong financial results in Q4 2022, showcasing consistent growth and profitability across regions.
Despite challenges like lower system ASP and heavy investments, the company's strategic initiatives and financial strength position it well for future growth.
Opportunities in international expansion, product portfolio enhancement, and market growth present avenues for sustained success in 2023 and beyond.
With a focus on operational efficiency, market adaptability, and category leadership, The Beauty Health Company remains poised for continued growth and profitability.

The Beauty Health Company (SKIN) reports robust Q1 performance and optimistic outlook for 2023

The Beauty Health Company (SKIN) showcased strong Q1 performance despite challenges, with a positive outlook for the year. The company's growth strategy, including the Cyndea system launch and boosters attachment rates, positions it well for future success.

Beauty Health Co. reports strong Q2, eyes global growth opportunities

The Beauty Health Company delivered strong Q2 results, reaffirming guidance despite challenges with Syndeo issues and gross margin pressure.
The company's focus on innovation, market resilience, and strategic investments positions it well for future growth and product expansion.
Opportunities in international markets, product enhancements, and margin improvement strategies present avenues for sustained performance and profitability.
Addressing challenges with Syndeo issues and gross margin pressure while leveraging market strengths and opportunities will be key to the company's continued success.

Beauty Health Co. addresses Syndeo challenges, focuses on growth

The Beauty Health Company is navigating challenges with Syndeo while focusing on customer-centric strategies and operational excellence under new leadership. Despite financial setbacks, the company aims for cost savings and growth opportunities through strategic transformation and reaccelerating Syndeo adoption in the U.S.

The Beauty Health Company reports solid Q4 performance and eyes growth in China market

The Beauty Health Company's Q4 2023 performance reflects revenue growth driven by APAC and EMEA, with operational efficiency and cost savings initiatives.
Strategic strengths include a strong cash position, inventory optimization efforts, and growth opportunities in the Chinese market.
Challenges include quality control issues, revenue declines in certain regions, and short-term financial pressures to be managed effectively.
Opportunities lie in expanding product offerings in China, improving gross margins, and addressing quality concerns to drive sustainable growth.

The Beauty Health Company (SKIN) surpasses Q1 targets, eyes growth

SKIN's Q1 performance exceeded expectations, with strong revenue and EBITDA figures, driven by consumables growth and operational improvements.
While facing challenges in equipment sales and product costs, SKIN's focus on excellence and growth opportunities position the company well for the future.
Analyst inquiries highlighted areas for improvement, but Marla Beck's confidence in growth avenues underscores a positive outlook for SKIN.

The Beauty Health Company (SKIN) exceeds Q3 revenue guidance, navigates market challenges

SKIN's Q3 2024 performance showcased revenue above guidance, profitability, and strategic advancements in sales, operations, and innovation.
While facing revenue declines and market challenges, SKIN's focus on profitability, margin expansion, and operational effectiveness signals a commitment to long-term success.
Navigating challenges with a proactive approach and seizing growth opportunities can position SKIN for sustained success and market resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LOS ANGELES, CA / ACCESSWIRE / November 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $STOCKS--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of The Beauty Health Company (SKIN) Investors.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of The Beauty Health Company (SKIN) Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN) securities between May 10, 2022 and November 13, 2023, inclusive (the “Class Period”). Beauty Health investors have until January 16, 2024 to file a lead plaintiff motion. Investors suffering losses on their Beauty Health investments are encouraged to contact the Law Of.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of The Beauty Health Company (SKIN) Investors

LOS ANGELES, CA / ACCESSWIRE / November 16, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Beauty Health securities between May 10, 2022 and November 13, 2023, both dates inclusive (the “Clas.

BEAUTY HEALTH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against The Beauty Health Company and Encourages Investors to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Alghazwi v. The Beauty Health Company, et al., Case No. 23-cv-9733, on behalf of persons and entities that purchased or otherwise acquired The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN) securities between May 10, 2022 and November 13, 2023, inclusive (the “Class.

SKIN CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against The Beauty Health Company

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN) investors concerning the Company's possible violations of federal securities laws. On November 13, 2023, Beauty Health announced its financial results for the third quarter of 2023. The Company disclosed that “[t]he quarter was overshadowed by lower-than-expected U.S. revenue and $63.1 million in restructuring charges.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of The Beauty Health Company (SKIN) on Behalf of Investors

LOS ANGELES, CA / ACCESSWIRE / November 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN) on behalf of Beauty Health stockholders. Our investigation concerns whether Beauty Health has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On November 13, 2023, Beauty Health announc.

BEAUTY HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating The Beauty Health Company on Behalf of Beauty Health Stockholders and Encourages Investors to Contact the Firm

OAKLAND, Calif.--(BUSINESS WIRE)---- $SKIN #SKIN--Gibbs Law Group is investigating potential legal claims on behalf of The Beauty Health Company (SKIN) investors.

Lost Money in the Beauty Health Company? Gibbs Law Group Investigates Potential Securities Law Violations

NEW YORK--(BUSINESS WIRE)---- $SKIN #classactionlawsuit--The law firm of Kirby McInerney LLP is investigating potential claims against The Beauty Health Company (“Beauty Health” or the “Company”) (NASDAQ: SKIN). The investigation concerns whether Beauty Health and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. On November 13, 2023, Beauty Health announced its financial results for the third quarter of 2023. The Company reported lower-than-expected U.

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against The Beauty Health Company (SKIN)

NEW YORK, NY / ACCESSWIRE / November 14, 2023 / Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of The Beauty Health Company ("Beauty Health") common stock (NASDAQ:SKIN). After the market closed on November 13, 2023, Beauty Health announced weak third quarter 2023 results and lowered its full year net sales guidance 16.5% and its adjusted EBITDA margin guidance 70.3% and suspended its long-term fiscal 2025 outlook.

Wolf Popper LLP Announces Investigation on Behalf of Investors in The Beauty Health Company

Shares of HydraFacial parent Beauty Health Co. lost more than half their value, after the skin treatment company reported a large surprise third-quarter loss and said its CEO was leaving, citing “many mistakes” made with regard to its Syndeo delivery system.

HydraFacial parent's stock cut in half after ‘many mistakes' leads to ugly quarter

Beauty Health (NASDAQ: SKIN ) stock is taking a beating on Tuesday after the aesthetic technologies and products company released its Q3 earnings report. The bad news for SKIN stock starts with the company's revenue of $97.4 million.

Why Is Beauty Health (SKIN) Stock Down 49% Today?

The Beauty Health Company (NASDAQ:SKIN ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Marla Beck - Interim CEO Michael Monahan - CFO Conference Call Participants Operator Good afternoon and welcome to The Beauty Health Company Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.

The Beauty Health Company (SKIN) Q3 2023 Earnings Call Transcript

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP Announces Investigation of The Beauty Health Company (SKIN) on Behalf of Investors.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of The Beauty Health Company (SKIN) on Behalf of Investors

Although the revenue and EPS for The Beauty Health Company (SKIN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The Beauty Health Company (SKIN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company announced financial results for the third quarter ended September 30, 2023.

BeautyHealth Reports Third Quarter 2023 Financial Results

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2023 financial results after market close on Monday, November 13, 2023. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.

BeautyHealth to Report Third Quarter 2023 Financial Results on November 13, 2023

The Beauty Health Company produces the Hydrafacial product, a high-end cosmetic procedure for deep skin cleaning. The company has experienced changes in leadership and a drop in gross margin due to issues with the rollout of its flagship Syndeo machine. The company is expanding into new directions, including selling refurbished machines, developing regional boosters, and entering the hair restoration industry.

The Beauty Health Company: State Of The Business Heading Into Q3 Earnings

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the launch of its first direct-to-consumer (DTC) sales channel on Chinese e-commerce platform Tmall, the world's largest third-party online and mobile commerce platform. On the Hydrafacial Tmall store, consumers can select from multiple luxe skin health treatment packages and redeem their purchase with any of a list of verified local Hydrafacial providers. “Hydrafac.

BeautyHealth Launches Hydrafacial Tmall Store in China in First Direct to Consumer Commercial Play

The mean of analysts' price targets for The Beauty Health Company (SKIN) points to a 122.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Does The Beauty Health Company (SKIN) Have the Potential to Rally 122.94% as Wall Street Analysts Expect?

Abbott Labs

While the direction of the stock markets is unpredictable, the growth of the aging population is entirely predictable. Along with an aging population come additional healthcare, beauty and wellness needs.

2 Stocks to Benefit from the Aging Population

LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced it will initiate a stock repurchase program on September 26, 2023 via Rule 10b5-1. The action follows the recent authorization by the Company's Board of Directors to repurchase up to $100 million of its common stock. The extent to which the Company repurchases shares, and the timing of such repurchases, will depend upon a variety of factors as determined by the Comp.

BeautyHealth to Initiate Stock Repurchase Program, Following Recent $100 Million Share Repurchase Authorization

Hims & Hers Health

Beauty stocks have not been pretty this year. Cosmetics retailer Ulta Beauty Inc. NASDAQ: ULTA and Estee Lauder Co. NYSE: EL shares are trading down 12.3% and 38.7%, respectively.

News for The Beauty Health Company Stock (SKIN)